Log In
Print this Print this

SparVax (Recombinant protective antigen (rPA) anthrax vaccine)

  Manage Alerts
Collapse Summary General Information
Company PharmAthene Inc.
DescriptionSecond-generation recombinant protective antigen (rPA) anthrax vaccine
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationAnthrax
Indication DetailsPrevent anthrax infection
Regulatory Designation
Partner Medison Pharma Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today